Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Microdermics has developed a proprietary hollow metal microneedle injection system designed to enable painless, minimally invasive intradermal drug and vaccine administration. The company’s technology aims to improve patient compliance by reducing needle phobia and risk of needlestick injuries while enabling self-administration. The company also develops biosensing applications for real-time health monitoring. Clinical results are not yet published; the focus remains on commercialization and regulatory clearance.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Microdermics.